A significant advance in cancer study is arising with the use of mini-antibodies to reactivate dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in many kinds of tumors, leading uncontrolled https://socialbookmarkgs.com/story21969535/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-pathway-for-malignant-management